SATB2 augments Δnp63α in head and neck squamous cell carcinoma

EMBO Reports

Volumn 11, Issue 10, 2010, Pages 777-783

  Chung, Jacky ^a,b   Lau, Joanne ^b   Cheng, Lynn S ^b   Grant, R Ian ^b   Robinson, Fiona ^b   Ketela, Troy ^a   Reis, Patricia P ^a   Roche, Olga ^a   Kamel Reid, Suzanne ^a   Moffat, Jason ^a   Ohh, Michael ^a   Perez Ordonez, Bayardo ^c   Kaplan, David R ^a,b   Irwin, Meredith S ^a,b,d  

^a UNIVERSITY OF TORONTO   (Canada)

^b HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^c UNIVERSITY HEALTH NETWORK   (Canada)

^d HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

apoptosis; chemotherapy; p63; SATB2; SCC

Indexed keywords

BINDING PROTEIN; PROTEIN P53; PROTEIN P63; PROTEIN P63ALPHA; SPECIAL AT RICH BINDING PROTEIN 2; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER RESISTANCE; COMPLEX FORMATION; GAMMA IRRADIATION; GENE REPRESSION; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RNA INTERFERENCE; SQUAMOUS CELL CARCINOMA; UPREGULATION;

APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL SURVIVAL; DNA-BINDING PROTEINS; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P53; HEAD AND NECK NEOPLASMS; HUMANS; MATRIX ATTACHMENT REGION BINDING PROTEINS; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 77957228723     PISSN: 1469221X     EISSN: 14693178     Source Type: Journal    
DOI: 10.1038/embor.2010.125     Document Type: Article

References (16)

1. Alcamo EA, Chirivella L, Dautzenberg M, Dobreva G, Farinas I, Grosschedl R, McConnell SK (2008) Satb2 regulates callosal projection neuron identity in the developing cerebral cortex. Neuron 57: 364-377 (Pubitemid 351179160)
2. Cam H, et al. (2006) p53 family members in myogenic differentiation and rhabdomyosarcoma development. Cancer Cell 10: 281-293 (Pubitemid 44512191)
3. Deyoung MP, Ellisen LW (2007) p63 and p73 in human cancer: defining the network. Oncogene 26: 5169-5183
4. DeYoung MP, Johannessen CM, Leong CO, Faquin W, Rocco JW, Ellisen LW (2006) Tumor-specific p73 up-regulation mediates p63 dependence in squamous cell carcinoma. Cancer Res 66: 9362-9368 (Pubitemid 44623630)
5. Dobreva G, Dambacher J, Grosschedl R (2003) SUMO modification of a novel MAR-binding protein, SATB2, modulates immunoglobulin mu gene expression. Genes Dev 17: 3048-3061 (Pubitemid 38040769)
6. Dobreva G, Chahrour M, Dautzenberg M, Chirivella L, Kanzler B, Farinas I, Karsenty G, Grosschedl R (2006) SATB2 is a multifunctional determinant of craniofacial patterning and osteoblast differentiation. Cell 125: 971-986 (Pubitemid 43810153)
7. Dos Reis PP, Bharadwaj RR, Machado J, Macmillan C, Pintilie M, Sukhai MA, Perez-Ordonez B, Gullane P, Irish J, Kamel-Reid S (2008) Claudin 1 overexpression increases invasion and is associated with aggressive histological features in oral squamous cell carcinoma. Cancer 113: 3169-3180
8. Flores ER (2007) The roles of p63 in cancer. Cell Cycle 6: 300-304 Forastiere A, Koch W, Trotti A, Sidransky D (2001) Head and neck cancer. N Engl J Med 345: 1890-1900
9. Han HJ, Russo J, Kohwi Y, Kohwi-Shigematsu T (2008) SATB1 reprogrammes gene expression to promote breast tumour growth and metastasis. Nature 452: 187-193 (Pubitemid 351380252)
10. Hibi K, Trink B, Patturajan M, Westra WH, Caballero OL, Hill DE, Ratovitski EA, Jen J, Sidransky D (2000) AIS is an oncogene amplified in squamous cell carcinoma. Proc Natl Acad Sci USA 97: 5462-5467 (Pubitemid 30313741)
11. Leong CO, Vidnovic N, DeYoung MP, Sgroi D, Ellisen LW (2007) The p63/ p73 network mediates chemosensitivity to cisplatin in a biologically defined subset of primary breast cancers. J Clin Invest 117: 1370-1380 (Pubitemid 46718425)
12. Pozzi S, Zambelli F, Merico D, Pavesi G, Robert A, Maltere P, Gidrol X, Mantovani R, Vigano MA (2009) Transcriptional network of p63 in human keratinocytes. PloS One 4: e5008
13. Rocco JW, Leong CO, Kuperwasser N, DeYoung MP, Ellisen LW (2006) p63 mediates survival in squamous cell carcinoma by suppression of p73-dependent apoptosis. Cancer Cell 9: 45-56 (Pubitemid 43069510)
14. Sun Q, Ming L, Thomas SM, Wang Y, Chen ZG, Ferris RL, Grandis JR, Zhang L, Yu J (2009) PUMA mediates EGFR tyrosine kinase inhibitor-induced apoptosis in head and neck cancer cells. Oncogene 28: 2348-2357
15. Yang A, Kaghad M, Caput D, McKeon F (2002) On the shoulders of giants: p63, p73 and the rise of p53. Trends Genet 18: 90-95 (Pubitemid 34127808)
16. Zangen R, Ratovitski E, Sidransky D (2005) DeltaNp63alpha levels correlate with clinical tumor response to cisplatin. Cell Cycle 4: 1313-1315 (Pubitemid 41437109)